Stroke is the fifth leading cause of mortality and has affected the lives of 6.3 million people living in the United States [1]. IV thrombolysis is one of the few effective treatments available for acute ischemic stroke (AIS), which is given within 3. 0-4.5 hours from the last time that someone observed the patient to be without neurological deficit [2]. This narrow therapeutic window forces physicians to make quick decisions, which often leads to administration of IV tPA to patients with stroke mimics [3]. While several studies proved IV tPA to be safe, risk of hemorrhage still exists [3,4]. Furthermore, mistaken IV thrombolysis makes care more expensive due to cost of the following ICU observation and drug itself [5-7]. Thus it is in the best interest of both patient and physician to avoid administering IV tPA to stroke mimic patients. This decision at times is very hard to make and different information from the history and presenting symptoms should be taken into account. One such symptom is presence of headache during stroke alert, which is comparatively easy to determine except for when a patient has aphasia and severe encephalopathy [8,9]. In this study we aimed to evaluate if the presence of headache during stroke alert in patients with focal neurological deficit can help the neurologist’s decision about IV thrombolysis.

      Patients: We retrospectively reviewed the charts of patients where stroke alert was activated during 2013 and collected the following information: age, gender, heart rate, systolic and diastolic blood pressure at presentation, NIHSS, presence and type of headache during stroke alert, and discharge diagnosis. All patients in our study had focal neurological deficit at presentation including but not limited to hemisensory loss, hemiparesis, hemianopia, facial weakness, aphasia or neglect. Patients younger than 18 years of age were excluded from the study because IV thrombolysis is not approved for this age group.

      Design: We calculated the proportion of stroke alert patients with and without headache who had IV thrombolysis. Then, we calculated the proportion of all stroke alert patients with and without headache who were ultimately diagnosed with AIS. At the end, we looked at how often the decision about IV thrombosis was correct and how presence of headache and its characteristics during stroke alert influenced this decision.

      Stroke alert protocol: The University of Oklahoma Medical Center (OUMC) emergency department charge nurse activates stroke alerts for all patients with new focal neurological deficit within 7 hours. Neurology residents evaluate the patient, perform anon-contrast head CT, and communicate with the attending physician regarding IV thrombolysis/thrombectomy. CT angiogram (CTA) of head and neck vessels is only done on selected patients. Physicians rarely could request emergent brain MRI to clarify diagnosis.

      Statistical analysis: We used chi square test to compare, between stroke alert patients with confirmed AIS or stroke mimics, the percentage who reported headaches. We regarded an alpha value of 0.05 as being statistically significant. We used SAS v9.4 for our analysis.

      A total of 326 stroke alert patients presented to OUMC during 2013. We excluded 68 patients from analysis because they were outside of the 4.5-hour window for consideration of IV tPA. We also excluded from the analysis another 81 patientswho had different contraindications for IV tPA administration (taking anticoagulants, platelets below 100k, recent surgeries). Two patients left the ED against medical advice. This study focuses on the remaining 175 patients, for whom the decision whether to provide IV tPA was based on clinical presentation and noncontrast head CT. Clinical characteristics of these patients are presented in Table 1.

      Headache during stroke alert and decision about IV thrombolysis: One hundred and seventy five patients were considered for IV thrombolysis: 62 of them presented with and 113 without headache. Seven out of 62 patients with headache were initially diagnosed in ED with ischemic stroke and received IV thrombolysis. On later evaluation all these 62 patients, including those who received IV thrombolysis, turned out to be stroke mimics. Forty five out of 113 patients without headache were initially diagnosed as ischemic stroke in ED and received IV thrombolysis. Nine of these 45 patients were later diagnosed as stroke mimics and 36 had ischemic stroke. The remaining 68 patients without headache were initially diagnosed with stroke mimics and did not receive IV thrombolysis. Four of them later were diagnosed with ischemic stroke and 64 confirmed to be stroke mimics. (Figure 1) Information about quality and location of headaches was not available in the chart.

Figure 1: Decision about IV thrombolysis on patient with and without headache including following discharge diagnosis.

      In general, after initial evaluation in ED patients who presented with headache less frequently received IV thrombolysis 7/62 (11%) than patients who presented without headache (45/113 (40%) (p<0.0001). After complete evaluation, including brain MRI, no patients with headache compared to 40 patients (36 who had IV thrombolysis + 4 who did not) without headache were diagnosed with ischemic stroke (p<0.0001). Table 2 shows the discharge diagnosis of all patients.

      This small retrospective study shows that patients with acute focal neurological deficit who had headache during stroke alert presentation were more commonly diagnosed with stroke mimics and less frequently had IV thrombolysis compared to patients who had no headache at presentation. In contrast, patients who presented without headache were more frequently diagnosed with AIS and received IV thrombolysis, than patients who presented with headache. As such, presence of headache may influence the neurologist decision whether or not to administer IV tPA.

      In our study, none of the 16 stroke mimic patients who received IV thrombolysis had bleeding complications, a finding that aligns with those of other authors, who proved that IV tPA in stroke mimics is safe [4]. However, besides bleeding risk, IV tPA adds unnecessary cost to the treatment of stroke mimics because of the drug itself and the following ICU or stroke unit observation [10]. Kleindorfer and colleagues found that the price for IV tPA has increased substantially from $30.50 per 1 mg in 2005 to $64.30 per 1 mg in 2014, which brought the cost of single IV tPA infusion to over $5,000 [11]. Cost for 24-hour ICU observation varies from $1,834 to $10,794 [12,13]. As a result all of this makes it financially beneficial for both hospitals and patients to avoid unnecessary IV thrombolysis.

      Although in our study no patients with headache had AIS, most likely because of small sample size or inability to report headache, literature reports frequency of headache in AIS patients from 7.4 to 11%. [8-9,14-15]. Headache during AIS is more common in younger patients, those with arterial dissection, and posterior circulation stroke, although characteristics of headache are not well described [8,16]. Thus, headache cannot be used as a single dichotomous variable in the decision whether to administer IV tPA. Rather, headache can help neurologists make better clinical decisions regarding IV thrombolysis in combination with other symptoms and history details. In our study stroke mimic patients were younger and had lower NIHSS (Table 1). We also noticed a trend that AIS patients had higher systolic blood pressure at presentation. We found no difference in diastolic blood pressure or heart rate of presenting patients.

Table 1

Table 1: Clinical characteristics of patients with discharge diagnosis of stroke vs. stroke mimic.

      Frequent headache in stroke mimics in our study corresponds to a high number of patients discharged with the diagnosis of migraine with motor aura (Table 2). Although initially designed, we could not determine headache characteristics in our patients because this information was not available in the chart. We relate this to the retrospective way of data collection and limited time for patient evaluation during stroke alert. Other limitations of this study include comparatively small sample size and physicians’ bias to diagnose stroke mimics, in particular migraine with aura. A high number of patients initially suspected for basilar artery thrombosis were later diagnosed with toxic-metabolic encephalopathy and reactivation of old deficits.

Table 2

Table 2: Discharge diagnosis of all patients with and without IV tPA.

      Overall, our study indicates that headache is a common symptom during stroke alert and is more frequently associated with stroke mimics than with AISs. The presence of headaches may help neurologists to think about stroke mimics, but at the same time it does not rule out AIS. Thorough evaluation of headache patients with acute focal neurological deficit is still necessary. Although brain MRI better differentiates strokes from stroke mimics it is rarely available in community hospitals in emergency settings [17]. Other clinical features besides headache such as young age, low NIHSS, recurrent admissions with similar symptoms, and absence of a trial fibrillation or old strokes on head CT may also help to suspect a stroke mimic. Future studies should concentrate on validating and organizing these symptoms into a scale in order to increase the probability of reserving thrombolysis for real AISs.